CORE D: BIOMARKER CORE
CORE D: BIOMARKER CORE
批准号:
10259844
负责人:
Peyton Jacob
金额:
$19.34万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-09-19 至 2023-08-31
关键词:
AerosolsAlkaloidsAnalytical ChemistryAnimalsBehaviorBiologicalBiological AssayBiological MarkersChemicalsCollaborationsCommunicationComplexDevelopmentElectronic cigaretteEmerging Tobacco ProductsExposure toFosteringGoalsGoldHealthIn VitroIndividualLaboratoriesLeadMass FragmentographyMeasuresMethodsPoisonProtocols documentationRegulationResearchResearch PersonnelResearch PriorityRiskSamplingSystemTobaccoTobacco useToxicologyanalytical methodbehavioral economicsbiomarker developmentexperienceheated tobacco productsimprovedinterestmass spectrometernicotine exposureproduct developmenttobacco exposuretobacco products
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
Exposure assessment is necessary for evaluating the health effects of tobacco use. Measuring exposure to
toxic and addictive substances is important for achieving the integrative theme of this TCORS, that
understanding combined health effects, behavior, and impact analysis will provide actionable information
for regulation of and public communications about current and emerging tobacco products The Biomarker Core
will contribute to this goal through three specific aims: (1) Provide analytical chemistry support for UCSF
TCORS investigators; (2) Continue and expand cross-TCORS collaborations by making available state-of-the-
art analytical methods to foster such collaborations; (3) Develop new biomarkers of exposure to tobacco
products. The Biomarker Core will identify new biomarkers of exposure and potential harm for new and
emerging tobacco products, in particular e-cigarettes and heat-not-burn (HNB) products. The Biomarker Core
will support studies carried out by TCORS investigators by analysis of biofluid samples for biomarkers of
exposure and potential harm (Projects 1-4), and by analyzing tobacco products (e-cigarettes and HNB
products) and their aerosols (Projects 1-3) for harmful and potentially harmful chemicals (HPHCs). Dr. Jacob
and his senior laboratory staff have more than 30 years' experience in supporting large-scale studies and
developing new biomarkers and analytical methods. The Biomarker Core laboratory will measure tobacco
alkaloids and a wide range of toxic substances and other components of interest in both products and their
aerosols. The core will assist the investigators of Projects 1, 2, and 3 in implementing protocols that will
generate aerosols for chemical analysis and for delivery to in vitro systems and animals for toxicology studies.
The analytical methods employed by the Biomarker Core are mostly chromatographic–mass spectrometric
(GC-MS and LC-MS/MS) performed on triple quadrupole mass spectrometers, generally considered the gold
standard for quantitative analysis of complex biological samples. As in our current TCORS, the Biomarker Core
also expects to use its methods in collaborations with other TCORS beyond UCSF. Providing state-of-the-art
exposure assessment to the individual projects, developing improved exposure assessment measures, and
identifying substances in new and emerging tobacco products and their aerosols that lead to toxic substance
exposure could contribute to the development of product standards for potential reduced risk products, as well
as advance the field of tobacco exposure assessment in general.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Core C: Biomarkers p426-450
-
批准号:8592344
-
项目类别:
-
资助金额:$86.01万
-
财政年份:2013
-
负责人:Peyton Jacob
-
依托单位:
CORE D: BIOMARKER CORE
-
批准号:10468890
-
项目类别:
-
资助金额:$17.51万
-
财政年份:2013
-
负责人:Peyton Jacob
-
依托单位:
Liquid Chromatograph-Triple Quadrupole Mass Spectrometer
-
批准号:7792007
-
项目类别:
-
资助金额:$44.8万
-
财政年份:2010
-
负责人:Peyton Jacob
-
依托单位:
Administrative Core
-
批准号:10205005
-
项目类别:
-
资助金额:$18.72万
-
财政年份:1999
-
负责人:Peyton Jacob
-
依托单位:
Drug Dependence Clinical Research Program
-
批准号:10205003
-
项目类别:
-
资助金额:$78.29万
-
财政年份:1999
-
负责人:Peyton Jacob
-
依托单位:
Administrative Core
-
批准号:10627880
-
项目类别:
-
资助金额:$18.72万
-
财政年份:1999
-
负责人:Peyton Jacob
-
依托单位:
Drug Dependence Clinical Research Program
-
批准号:10025048
-
项目类别:
-
资助金额:$78.29万
-
财政年份:1999
-
负责人:Peyton Jacob
-
依托单位:
Drug Dependence Clinical Research Program
-
批准号:10627879
-
项目类别:
-
资助金额:$78.29万
-
财政年份:1999
-
负责人:Peyton Jacob
-
依托单位:
Research Support Core
-
批准号:10205006
-
项目类别:
-
资助金额:$51.94万
-
财政年份:1999
-
负责人:Peyton Jacob
-
依托单位:
Administrative Core
-
批准号:10417191
-
项目类别:
-
资助金额:$18.72万
-
财政年份:1999
-
负责人:Peyton Jacob
-
依托单位:
Research Support Core
-
批准号:10417192
-
项目类别:
-
资助金额:$51.94万
-
财政年份:1999
-
负责人:Peyton Jacob
-
依托单位:
Research Support Core
-
批准号:10627884
-
项目类别:
-
资助金额:$51.94万
-
财政年份:1999
-
负责人:Peyton Jacob
-
依托单位:
Drug Dependence Clinical Research Program
-
批准号:10417190
-
项目类别:
-
资助金额:$78.29万
-
财政年份:1999
-
负责人:Peyton Jacob
-
依托单位:
Research Support Core
-
批准号:10025050
-
项目类别:
-
资助金额:$51.94万
-
财政年份:--
-
负责人:Peyton Jacob
-
依托单位:
Core C: Biomarkers p426-450
-
批准号:8754525
-
项目类别:
-
资助金额:$37.88万
-
财政年份:--
-
负责人:Peyton Jacob
-
依托单位:
Administrative Core
-
批准号:10025049
-
项目类别:
-
资助金额:$18.72万
-
财政年份:--
-
负责人:Peyton Jacob
-
依托单位:
Core C: Biomarkers p426-450
-
批准号:8920111
-
项目类别:
-
资助金额:$43.72万
-
财政年份:--
-
负责人:Peyton Jacob
-
依托单位:
国内基金
海外基金
Iboga alkaloids骨架导向的不对称串联反应构建吖庚环并[4,5-b]吲哚及其在全合成中的应用
-
批准号:21801032
-
项目类别:青年科学基金项目
-
资助金额:26.0万元
-
批准年份:2018
-
负责人:陈惠渝
-
依托单位: